Before meningitis outbreak, firm avoided sanctions

Your Health Matters

Pharmaceutical compounding company NECC, a producer of the steroid methylprednisolone acetate, is seen in Framingham, MassachusettsBOSTON (Reuters) – The pharmacy tied to a deadly U.S. meningitis outbreak escaped harsh punishment from health regulators several times in the years leading up to a deadly U.S. meningitis outbreak that has raised questions about oversight of the customized drug mixing industry, newly released state records show. Problems at the New England Compounding Center (NECC) in Framingham, Massachusetts, date as far back as 1999, the year after it began operations, according to hundreds of pages of documents obtained under a Freedom of Information Act request. …

facebookShare on Facebook
TwitterTweet
FollowFollow us
PinterestSave